MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma

Yusuke Yamamoto; Nobuyoshi Kosaka; Minoru Tanaka; Fumiaki Koizumi; Yae Kanai; Takayuki Mizutani; Yoshiki Murakami; Masahiko Kuroda; Atsushi Miyajima; Takashi Kato; Takahiro Ochiya

doi:10.3109/13547500903150771

MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma

Yusuke Yamamoto, Nobuyoshi Kosaka, Minoru Tanaka, Fumiaki Koizumi, Yae Kanai, Takayuki Mizutani, Yoshiki Murakami, Masahiko Kuroda, Atsushi Miyajima, Takashi Kato, Takahiro Ochiya^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

197 Citations (Scopus)

Abstract

We identified that microRNA expression changed dynamically during liver development and found that miR-500 is an oncofetal miRNA in liver cancer. miR-500 was abundantly expressed in several human liver cancer cell lines and 45% of human hepatocellular carcinoma (HCC) tissue. Most importantly, an increased amount of miR-500 was found in the sera of the HCC patients. In fact, miR-500 levels in sera of the HCC patients returned to normal after the surgical treatment in three HCC patients. Our findings reveal that diverse changes of miRNAs occur during liver development and, one of these, miR-500 is an oncofetal miRNA relevant to the diagnosis of human HCC.

Original language	English
Pages (from-to)	529-538
Number of pages	10
Journal	Biomarkers
Volume	14
Issue number	7
DOIs	https://doi.org/10.3109/13547500903150771
Publication status	Published - 2009
Externally published	Yes

Keywords

Hepatocellular carcinoma, liver development, diagnosis
miR-500
miRNA

ASJC Scopus subject areas

Biochemistry
Clinical Biochemistry
Health, Toxicology and Mutagenesis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/13547500903150771

Cite this

@article{4778c0c8e01346989f21a6796e98ee7c,

title = "MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma",

abstract = "We identified that microRNA expression changed dynamically during liver development and found that miR-500 is an oncofetal miRNA in liver cancer. miR-500 was abundantly expressed in several human liver cancer cell lines and 45% of human hepatocellular carcinoma (HCC) tissue. Most importantly, an increased amount of miR-500 was found in the sera of the HCC patients. In fact, miR-500 levels in sera of the HCC patients returned to normal after the surgical treatment in three HCC patients. Our findings reveal that diverse changes of miRNAs occur during liver development and, one of these, miR-500 is an oncofetal miRNA relevant to the diagnosis of human HCC.",

keywords = "Hepatocellular carcinoma, liver development, diagnosis, miR-500, miRNA",

author = "Yusuke Yamamoto and Nobuyoshi Kosaka and Minoru Tanaka and Fumiaki Koizumi and Yae Kanai and Takayuki Mizutani and Yoshiki Murakami and Masahiko Kuroda and Atsushi Miyajima and Takashi Kato and Takahiro Ochiya",

note = "Funding Information: We thank Dr Lim Chun Ren and Dr Kenichi Matsubara at DNA Chip Research Inc. for supporting the processing of microarray data. We thank Ms Ayako Inoue and Ms Nachi Namatame for their excellent technical assistance. This work was supported in part by a Grant-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control; Health Science Research Grants for Research on the Hepatitis C Virus from the Ministry of Health, Labour, Welfare of Japan; the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio); a Grant for Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists.",

year = "2009",

doi = "10.3109/13547500903150771",

language = "English",

volume = "14",

pages = "529--538",

journal = "Biomarkers",

issn = "1354-750X",

publisher = "Informa Healthcare",

number = "7",

}

TY - JOUR

T1 - MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma

AU - Yamamoto, Yusuke

AU - Kosaka, Nobuyoshi

AU - Tanaka, Minoru

AU - Koizumi, Fumiaki

AU - Kanai, Yae

AU - Mizutani, Takayuki

AU - Murakami, Yoshiki

AU - Kuroda, Masahiko

AU - Miyajima, Atsushi

AU - Kato, Takashi

AU - Ochiya, Takahiro

N1 - Funding Information: We thank Dr Lim Chun Ren and Dr Kenichi Matsubara at DNA Chip Research Inc. for supporting the processing of microarray data. We thank Ms Ayako Inoue and Ms Nachi Namatame for their excellent technical assistance. This work was supported in part by a Grant-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control; Health Science Research Grants for Research on the Hepatitis C Virus from the Ministry of Health, Labour, Welfare of Japan; the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio); a Grant for Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists.

PY - 2009

Y1 - 2009

N2 - We identified that microRNA expression changed dynamically during liver development and found that miR-500 is an oncofetal miRNA in liver cancer. miR-500 was abundantly expressed in several human liver cancer cell lines and 45% of human hepatocellular carcinoma (HCC) tissue. Most importantly, an increased amount of miR-500 was found in the sera of the HCC patients. In fact, miR-500 levels in sera of the HCC patients returned to normal after the surgical treatment in three HCC patients. Our findings reveal that diverse changes of miRNAs occur during liver development and, one of these, miR-500 is an oncofetal miRNA relevant to the diagnosis of human HCC.

AB - We identified that microRNA expression changed dynamically during liver development and found that miR-500 is an oncofetal miRNA in liver cancer. miR-500 was abundantly expressed in several human liver cancer cell lines and 45% of human hepatocellular carcinoma (HCC) tissue. Most importantly, an increased amount of miR-500 was found in the sera of the HCC patients. In fact, miR-500 levels in sera of the HCC patients returned to normal after the surgical treatment in three HCC patients. Our findings reveal that diverse changes of miRNAs occur during liver development and, one of these, miR-500 is an oncofetal miRNA relevant to the diagnosis of human HCC.

KW - Hepatocellular carcinoma, liver development, diagnosis

KW - miR-500

KW - miRNA

UR - http://www.scopus.com/inward/record.url?scp=70449412171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449412171&partnerID=8YFLogxK

U2 - 10.3109/13547500903150771

DO - 10.3109/13547500903150771

M3 - Article

C2 - 19863192

AN - SCOPUS:70449412171

SN - 1354-750X

VL - 14

SP - 529

EP - 538

JO - Biomarkers

JF - Biomarkers

IS - 7

ER -

MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this